Arch Capital Group Ltd. (ACGLP), DHT Holdings (DHT), Home Bancorp (HBCP) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Arch Capital Group Ltd. (ACGLP) | 25.38 | -0.03% | 5.18% | 2021-07-01 22:31:27 |
| 2 | DHT Holdings (DHT) | 6.50 | -2.55% | 2.4% | 2021-06-28 22:43:05 |
| 3 | Home Bancorp (HBCP) | 38.11 | -0.16% | 2.39% | 2021-06-30 21:14:26 |
| 4 | Astrazeneca (AZN) | 60.79 | 0.8% | 2.34% | 2021-07-02 15:36:03 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Arch Capital Group Ltd. (ACGLP) - Dividend Yield: 5.18%
Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service contract reimbursement products; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile, and inland marine products. It also provides property, energy, marine, and aviation insurance; travel insurance; accident, disability, and medical plan insurance coverages; captive insurance programs; employer's liability; and contract and commercial surety coverages. This segment markets its products through a group of licensed independent retail and wholesale brokers. Its Reinsurance segment provides reinsurance for third party liability and workers' compensation exposures; marine and aviation reinsurance; surety, accident and health, workers' compensation catastrophe, agriculture, trade credit, and political risk products; reinsurance protection for catastrophic losses, and personal lines and commercial property exposures; life reinsurance; casualty clash; and risk management solutions. This segment markets its reinsurance products through brokers. The company's Mortgage segment offers direct mortgage insurance and mortgage reinsurance. The company was founded in 1995 and is based in Pembroke, Bermuda.
Volume
Today's last reported volume for Arch Capital Group Ltd. is 17787, 35.08% below its average volume of 27398.
Arch Capital Group Ltd.'s last close was $25.45, 2.97% below its 52-week high of $26.23.
Arch Capital Group Ltd.'s Revenue
Year-on-year quarterly revenue growth grew by 48.5%, now sitting on 9.27B for the twelve trailing months.
Arch Capital Group Ltd.'s Stock Yearly Top and Bottom Value
Arch Capital Group Ltd.'s stock is valued at $25.38 at 11:15 EST, below its 52-week high of $26.23 and higher than its 52-week low of $24.35.
Arch Capital Group Ltd.'s Moving Average
Arch Capital Group Ltd.'s value is under its 50-day moving average of $25.41 and under its 200-day moving average of $25.54.More news about Arch Capital Group Ltd..
2. DHT Holdings (DHT) - Dividend Yield: 2.4%
DHT Holdings, Inc., through its subsidiaries, owns and operates crude oil tankers primarily in Monaco, Singapore, Oslo, and Norway. As of March 19, 2020, it had a fleet of 27 very large crude carriers with a capacity of 8,360,850 deadweight tons. The company was founded in 2005 and is headquartered in Hamilton, Bermuda.
Volume
Today's last reported volume for DHT Holdings is 2061840, 18.63% below its average volume of 2533970.
DHT Holdings's last close was $6.20, 9.36% below its 52-week high of $6.84.
DHT Holdings's Sales
DHT Holdings's sales growth is a negative 73.3% for the present quarter and a decline by 44.2% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 108.6% and a negative 105.9%, respectively.
DHT Holdings's Revenue
Year-on-year quarterly revenue growth declined by 59%, now sitting on 566.11M for the twelve trailing months.
DHT Holdings's Stock Yearly Top and Bottom Value
DHT Holdings's stock is valued at $6.50 at 11:15 EST, below its 52-week high of $6.84 and way above its 52-week low of $4.52.
DHT Holdings's Moving Average
DHT Holdings's worth is higher than its 50-day moving average of $6.26 and way higher than its 200-day moving average of $5.90.More news about DHT Holdings.
3. Home Bancorp (HBCP) - Dividend Yield: 2.39%
Home Bancorp, Inc. operates as the holding company for Home Bank, National Association that provides various banking products and services in Louisiana and Mississippi. It offers deposits products, including interest-bearing and noninterest-bearing checking, money market, savings, and certificates of deposit accounts. The company also provides various loan products, such as one-to four-family first mortgage loans, home equity loans and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. In addition, it invests in securities; and offers online banking services. The company operates through a network of 20 banking offices in the Acadiana, four banking offices in Baton Rouge, six banking offices in the Greater New Orleans area, six banking offices in the Northshore region, three banking offices in Natchez, and one banking office in Vicksburg. Home Bancorp, Inc. was founded in 1908 and is headquartered in Lafayette, Louisiana.
Volume
Today's last reported volume for Home Bancorp is 30299, 77.32% above its average volume of 17087.
Home Bancorp's last close was $38.85, 2.48% under its 52-week high of $39.84.
The company's growth estimates for the ongoing quarter and the next is 317.2% and 1%, respectively.Home Bancorp's Revenue
Year-on-year quarterly revenue growth grew by 67.5%, now sitting on 106.22M for the twelve trailing months.
Home Bancorp's Stock Yearly Top and Bottom Value
Home Bancorp's stock is valued at $38.11 at 11:15 EST, below its 52-week high of $39.84 and way higher than its 52-week low of $22.71.
Home Bancorp's Moving Average
Home Bancorp's worth is below its 50-day moving average of $38.63 and higher than its 200-day moving average of $34.88.More news about Home Bancorp.
4. Astrazeneca (AZN) - Dividend Yield: 2.34%
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Volume
Today's last reported volume for Astrazeneca is 5170310, 34.82% below its average volume of 7932150.
Astrazeneca's last close was $60.31, 7.13% below its 52-week high of $64.94.
Astrazeneca's Sales
Astrazeneca's sales growth is 17% for the ongoing quarter and 27.3% for the next.
Astrazeneca's Revenue
Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 27.58B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Astrazeneca's stock is considered to be oversold (<=20).
Astrazeneca's Stock Yearly Top and Bottom Value
Astrazeneca's stock is valued at $60.79 at 11:15 EST, under its 52-week high of $64.94 and way above its 52-week low of $46.48.
Astrazeneca's Moving Average
Astrazeneca's value is higher than its 50-day moving average of $57.61 and way above its 200-day moving average of $52.39.More news about Astrazeneca.